Fulyzaq approved for ART-related diarrhea in HIV/AIDS

Fulyzaq approved for ART-related diarrhea in HIV/AIDS
The first medication to treat diarrhea in people with HIV/AIDS who take antiretroviral drugs has been approved by the U.S. Food and Drug Administration.

(HealthDay)—The first medication to treat diarrhea in people with HIV/AIDS who take antiretroviral drugs has been approved by the U.S. Food and Drug Administration.

Fulyzaq (crofelemer) is sanctioned for people whose diarrhea is not caused by an infection or but by the antiretroviral drugs used to combat HIV/AIDS, the FDA said in a news release. The drug is derived from the red sap of the Croton lechleri plant.

Fulyzaq's safety and effectiveness were evaluated in a clinical study involving 374 people who were HIV-positive, on stable drug therapy, and who had had diarrhea for one month or longer. About 17.6 percent of people who took Fulyzaq had a positive "clinical response," compared with a positive response among 8 percent of people who took a placebo.

All participants in the study were tested to confirm that their symptoms were not caused by an infection or , the FDA said. Common side effects to Fulyzaq's use were upper , bronchitis, cough, flatulence, and an increase in the liver enzyme bilirubin.

The drug is distributed by Salix Pharmaceuticals, based in Raleigh, N.C.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Xeljanz approved for rheumatoid arthritis

Nov 07, 2012

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Afinitor approved for advanced breast cancer

Jul 23, 2012

(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food ...

Gattex approved for short bowel syndrome

Dec 22, 2012

(HealthDay)—Gattex (teduglutide) has been approved by the U.S. Food and Drug Administration to treat nutritional problems caused by short bowel syndrome.

US approves new HIV drug

May 21, 2011

The US Food and Drug Administration on Friday approved a new drug, Edurant, to fight HIV in combination with other antiretrovirals already on the market.

Recommended for you

A new tool in drug overdose prevention

Oct 30, 2014

The Center for Disease Control reported earlier this month that the heroin overdose death rate across 28 states it surveyed doubled between 2010 and 2012. This sharp increase and the chilling statistics that say more than 11 ...

Nasal spray treats heroin overdose

Oct 28, 2014

"Every year, drug overdoses are responsible for roughly 1000 ambulance calls in Oslo," says Arne Skulberg, an anaesthesiologist, a PhD candidate at NTNU and the 2014 winner of Norway's Researcher Grand Prix ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.